Abstract-Intraventricular administration of nicotine produced a biphasic effect, consisting of an initial rise then a slight fall in blood pressure in unanaesthetized rats. Spontaneously hypertensive rats (SHR) showed increased pressor responses, but these responses were within normal limits in renal hypertensive and DOCA-saline hypertensive rats. The blood pressure response to nicotine in SHR was abolished by intraventricular administration of hexamethonium, but not by atropine given via the same route. Central phentolamine and 6-hydroxydopamine did not affect the pressor response to nicotine. The pressor effect of nicotine in SHR was markedly diminished after removal of the adrenals and abolished after bilateral adrenalectomy plus peripheral 6-hydroxydopamine. These results indicate that the pressor response to intraventricular nicotine is increased in SHR. The pressor effect of nicotine may result from the activation of the central nicotinic receptor sites, which may cause the release of catechol amines both from the adrenal medulla and adrenergic nerve terminals.
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Brain acetylcholine has been implicated in the central control of cardiovascular function (1) (2) (3) (4) . However, little information is available concerning the possible involve ment of central cholinergic mechanisms in the pathophysiology of arterial hypertension. In a previous study we found that pressor response to intravenous physostigmine was increased in SHR (5) .
When injected into a lateral ventricle of the cat brain, nicotine produced a fall in blood pressure (6) . Furthermore, superfusion of nicotine at the medullary levels produced both pressor and depressor effects in cats (3) . The purpose of the present study was to examine the possible involvement of central nicotinic mechanisms in the main tenance of hypertension in SHR by testing the effect of intraventricular nicotine admin istration on blood pressure in this strain of rats.
MATERIALS AND METHODS
Five to 10-month-old female SHR and age-matched normotensive Wistar Kyoto rats (WKR) were used. For the production of renal hypertension and DOCA-saline hyper tension, male Wistar rats were used at the age of 5 weeks.
Renal hypertension was induced by occlusion of the left renal artery with a silk thread (the two kidney Goldblatt model) (7) . For the induction of DOCA saline hypertension, rats were subjected to left nephrectomy, DOCA (40 mg/kg) was given s.c. twice per week from the 5th week onwards, and 1 % NaCl was substituted for drinking water (8 On the morning of experiments, each rat was anaesthetized with ether and the femoral artery and vein were cannulated for the recording of mean arterial pressure and for i.v. administration of drugs, respectively. Blood pressure was measured using a Toyo Meas. pressure transducer (MPU-0.5-290).
Electrically integrated values of mean arterial pressure were recorded. Experiments were started 3 hr after surgery, at which time the animals had recovered from the ether anaes thesia. In order to simplify the cardiovascular response to intraventricular or intravenous nicotine administration, peripheral muscarinic receptors were blocked by i.v. methylatropine
(1 mg/kg), this agent producing a slight fall in blood pressure (2-5 mmHg).
Drugs were dissolved in physiological saline and given i.v.c. in a volume of 5 ill/ 100 g body weight and i.v. in a volume of 0.1 ml/100 g body weight. Nicotine was administered i.v.c. at intervals of 90 min.
Drugs used were nicotine tartrate (Wako Pure Chemical.), atropine methyl bromide (Sigma), atropine sulphate (E. Merck), hexamethonium bromide (Yamanouchi Phar maceutical Company), phentolamine me sylate (Ciba), 6-hydroxydopamine hydro bromide (Sigma), /-noradrenaline hydro chloride (Sigma) and /-adrenaline bitartrate (Sigma). All doses refer to the free base.
Differences between means were analyzed by Student's t-test, paired when comparing treated and untreated SHR, and unpaired when comparing hypertensive and control rats. At p-values below 0.05 the difference was considered significant.
RESULTS
Vascular response to intraventricularly injected nicotine in experimentally hyper tensive and normotensive rats: Intraventricular nicotine (1 and 10 lug/kg) administration in SHR pretreated with i.v. methylatropine produced a biphasic effect that is an initial marked rise then a slight fall in blood pressure (Fig. 1 ) . The pressor response was of short duration, usually lasting no longer than 3 min, while the depressor response lasted 8-20 min. These pressor responses to intraventricular nicotine in SHR were significantly greater than those in control (WKR), while renal hypertensive and DOCA-saline hypertensive rats showed no significant difference in pressor response to nicotine as compared to the normotensive control (NR) ( Table 1) . Depressor responses of these normotensive and hypertensive rats to intraventricular nicotine were too small (3-8 mmHg) for comparison. Intraventricular administration of the vehicle produced no appreciable changes in blood pressure in these normo tensive and three types of hypertensive rats. In another five paired experiments, 6-month old male SHR and WKR were compared. Nicotine (10 /tg/kg) administered i.v.c. to SHR produced an increase of 62±5 mmHg in blood pressure, as compared with 19±4 mmHg in WKR (P<0.001).
Vascular response to intraventricularly in jected nicotine before and after central administration of cholinergic antagonists in SHR: When nicotine (1 /cg/kg) was admin istered into the lateral ventricle of SHR brain at intervals of 90 min, the blood pressure responses were much the same (Table 2) .
Hexamethonium (10 /Lg/kg) given i.v.c. 10 min before the second administration of nicotine all but abolished the blood pressure response to nicotine.
Atropine (100 !cg/kg) given i.v.c. 10 min before the second administration of nicotine had no effect on blood pressure response to nicotine. These cholinergic antagonists did not affect the basal blood pressure.
Vascular response to intraventricularly administered nicotine after central adminis tration of phentolamine and 6-hydroxy dopamine in SHR: Phentolamine (50,g) was intraventricularly administered 60 min before the microinjection of nicotine into the lateral ventricle of SHR brain. The a adrenergic blocking agent produced no appreciable effect on the basal blood pressure and pressor response to nicotine (10 leg/kg) after i.v. methylatropine (53±4 mmHg, n=4).
In 6 experiments, rats were given 6-hydroxy dopamine (250 rig) i.v.c. 3 days before the dosing with nicotine.
No significant differ ence in the basal blood pressure (155±2 mmHg) and the pressor response to 10 iig/kg of nicotine (56±4 mmHg) was seen in the centrally sympathectomized SHR, as com pared to findings in the untreated SHR, as shown in Table 1 . Vascular response to intraventricularly injected nicotine after bilateral adrenalectomy and/or peripheral administration of 6-hy droxydopamine in SHR:
To determine whether or not the adrenal medulla parti cipates in the development of the pressor response to nicotine, bilateral adrenalectomy was performed 3-4 hr before the experiments. Under these experimental conditions, pressor responses to intraventricular administration of nicotine (1 and 10 iig/kg) in SHR after i.v. methylatropine were significantly reduced (Table 3) . In 5 experiments, 6-hydroxy dopamine (100 mg/kg) was given i.p. 24 hr before the experiments. Removal of adrenal glands in the 6-hydroxydopamine-treated SHR abolished the pressor response to nicotine (10 /cg/kg) given i.v.c. after i.v. methylatropine (Table 3) . Although treat ment with peripheral 6-hydroxydopamine and bilateral adrenalectomy lowered basal blood pressure to 62±4 mmHg, i.v. admin istered noradrenaline (1 ug/kg) still produced a greater pressor response (121 ±7 mmHg). Vascular response to intravenously admin istered nicotine, noradrenaline and adrenaline in SHR and WKR: To determine if leakage of nicotine into the periphery contributes to the cardiovascular responses to this alkaloid given intraventricularly, the effects of intravenously administered nicotine on blood pressure were examined after 1. V. methylatropine
(1 mg/kg). In SHR i.v. administration of nicotine (1 ,pig/kg) did not affect blood pressure and a higher dose of nicotine (10 iig/kg) produced only a slight increase in blood pressure.
No noticeable changes in blood pressure were observed even after 10 ILg/kg of nicotine were given intravenously to WKR (Table 4 ). Pressor re sponses to i.v. noradrenaline (0.25 and 1 /cg/kg) or i.v. adrenaline (0.25 and 1 /Lg/kg) in SHR pretreated with i.v. methylatropine were much the same as those in WKR (Table 4) .
DISCUSSION
The present study shows that the pressor response to intraventricularly administered nicotine is increased in SHR. This enhanced response appears to be specific for the genetic hypertension in SHR, since the response of renal hypertensive and DOCA saline hypertensive rats was essentially the same as that of normotensive controls.
Even with a dose of 10 ,ug/kg, i.v. nicotine had no effects on blood pressure in WKR and only slight pressor effects in SHR, indicating that the blood pressure responses to intraventricular nicotine are of central origin. Hexamethonium, a nicotinic receptor blocking agent, blocked pressor responses to intraventricular nicotine at the central receptors.
In contrast, atropine, a muscarinic receptor blocking agent, was not an effective antagonist.
Thus, the pressor response to centrally administered nicotine appears to be the result of a specific nicotinic mechanism.
It has been suggested that the pressor response to electrical stimulation of the posterior hypothalamus (9, 10) 
